• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌患者肠道真菌群谱的改变

Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma.

作者信息

Zhang Lilong, Chen Chen, Chai Dongqi, Kuang Tianrui, Deng Wenhong, Wang Weixing

机构信息

Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

出版信息

Front Microbiol. 2023 Jan 6;13:1090392. doi: 10.3389/fmicb.2022.1090392. eCollection 2022.

DOI:10.3389/fmicb.2022.1090392
PMID:36687597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9853418/
Abstract

OBJECTIVE

Intrahepatic cholangiocarcinoma (ICC) is a silent liver malignancy with an increasing incidence. Gut mycobiota plays a crucial role in benign liver diseases; however, its correlation with ICC remains elusive. This study aimed to elucidate fungal differences in patients with ICC compared to healthy controls.

METHODS

The 40 fecal samples from 23 ICC patients and 17 healthy controls were collected and analyzed using ITS2 rDNA sequencing. Obtaining the OTUs and combining effective grouping, we carried out the biodiversity and composition of the fungi, as well as FUNGuild functional annotation.

RESULTS

Our results revealed the presence of intestinal fungal dysbiosis with significant enrichment of opportunistic pathogenic fungi such as and and significant depletion of the beneficial fungus in ICC patients compared with healthy controls. Alpha-diversity analysis demonstrated that patients with ICC showed decreased fungal diversity compared to healthy controls. Beta diversity analysis indicated that the two groups exhibited significant segregated clustering. Besides, was found to be significantly more abundant in the ICC patients with TNM stage III-IV than those with stage I-II. The FUNGuild functional classification predicted that pathotrophs were the most abundant taxon in the ICC group, well above their abundance in healthy controls.

CONCLUSION

This study indicates that dysbiosis of the fecal mycobiome might be involved in ICC development. Further research into gut fungi may contribute to new therapeutic options for ICC patients.

摘要

目的

肝内胆管癌(ICC)是一种隐匿性肝脏恶性肿瘤,发病率呈上升趋势。肠道微生物群在良性肝脏疾病中起关键作用;然而,其与ICC的相关性仍不明确。本研究旨在阐明ICC患者与健康对照者之间的真菌差异。

方法

收集23例ICC患者和17例健康对照者的40份粪便样本,采用ITS2 rDNA测序进行分析。获得操作分类单元(OTUs)并结合有效分组,我们对真菌的生物多样性、组成以及FUNGuild功能注释进行了分析。

结果

我们的结果显示,与健康对照者相比,ICC患者存在肠道真菌生态失调,机会性致病真菌如 和 显著富集,有益真菌 显著减少。α多样性分析表明,与健康对照者相比,ICC患者的真菌多样性降低。β多样性分析表明,两组表现出明显的分离聚类。此外,发现TNM III-IV期ICC患者中的 比I-II期患者明显更丰富。FUNGuild功能分类预测,致病营养型是ICC组中最丰富的分类群,远高于其在健康对照者中的丰度。

结论

本研究表明,粪便真菌微生物群失调可能与ICC的发生有关。对肠道真菌的进一步研究可能有助于为ICC患者提供新的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/5322cce400f7/fmicb-13-1090392-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/611d7f7f3bae/fmicb-13-1090392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/71e650fb2271/fmicb-13-1090392-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/50d46ee2af58/fmicb-13-1090392-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/8f70d609f403/fmicb-13-1090392-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/5322cce400f7/fmicb-13-1090392-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/611d7f7f3bae/fmicb-13-1090392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/71e650fb2271/fmicb-13-1090392-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/50d46ee2af58/fmicb-13-1090392-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/8f70d609f403/fmicb-13-1090392-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868b/9853418/5322cce400f7/fmicb-13-1090392-g005.jpg

相似文献

1
Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma.肝内胆管癌患者肠道真菌群谱的改变
Front Microbiol. 2023 Jan 6;13:1090392. doi: 10.3389/fmicb.2022.1090392. eCollection 2022.
2
Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.肝细胞癌患者肠道真菌微生物组的特征。
J Transl Med. 2023 Feb 15;21(1):126. doi: 10.1186/s12967-023-03940-y.
3
Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.肠道共生真菌失调及其对注意缺陷多动障碍肠道通透性的影响。
J Child Psychol Psychiatry. 2023 Sep;64(9):1280-1291. doi: 10.1111/jcpp.13779. Epub 2023 Apr 5.
4
The gut mycobiome of the Human Microbiome Project healthy cohort.人类微生物组计划健康队列的肠道共生真菌组。
Microbiome. 2017 Nov 25;5(1):153. doi: 10.1186/s40168-017-0373-4.
5
disorder is associated with gastric carcinogenesis.紊乱与胃癌的发生有关。
Theranostics. 2021 Mar 5;11(10):4945-4956. doi: 10.7150/thno.55209. eCollection 2021.
6
A Clinical Study Provides the First Direct Evidence That Interindividual Variations in Fecal β-Lactamase Activity Affect the Gut Mycobiota Dynamics in Response to β-Lactam Antibiotics.一项临床研究首次提供了直接证据,表明粪便β-内酰胺酶活性的个体间差异会影响肠道微生物群对β-内酰胺类抗生素的反应动态。
mBio. 2022 Dec 20;13(6):e0288022. doi: 10.1128/mbio.02880-22. Epub 2022 Nov 30.
7
Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.机会性肠道真菌病原体的扩张与人类肝包虫病肠道炎症的发生。
Microbiol Spectr. 2022 Oct 26;10(5):e0145322. doi: 10.1128/spectrum.01453-22. Epub 2022 Sep 13.
8
Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.肠真菌失调和腹泻为主的肠易激综合征患者细菌-真菌相互作用改变:一项探索性研究。
Neurogastroenterol Motil. 2020 Nov;32(11):e13891. doi: 10.1111/nmo.13891. Epub 2020 May 25.
9
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.肠道共生真菌失调与黑色素瘤及抗 PD-1 治疗反应相关。
Cancer Immunol Res. 2024 Apr 2;12(4):427-439. doi: 10.1158/2326-6066.CIR-23-0592.
10
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.酒精性肝炎患者肠道真菌失调与真菌的全身免疫反应。
Hepatology. 2020 Feb;71(2):522-538. doi: 10.1002/hep.30832. Epub 2019 Aug 20.

引用本文的文献

1
Age and Tumor Stage Interplay in Intrahepatic Cholangiocarcinoma: Prognostic Factors, Mortality Trends, and Therapeutic Implications from a SEER-Based Analysis.肝内胆管癌中年龄与肿瘤分期的相互作用:基于监测、流行病学和最终结果(SEER)分析的预后因素、死亡率趋势及治疗意义
Diseases. 2025 Jan 25;13(2):31. doi: 10.3390/diseases13020031.
2
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.人类癌症中的真菌群落:分析挑战、分子机制及治疗意义。
Mol Cancer. 2025 Jan 15;24(1):18. doi: 10.1186/s12943-025-02227-8.
3
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids.

本文引用的文献

1
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?局部区域治疗在肝内胆管癌治疗中的应用:是否有足够的证据来指导当前的临床实践?
Curr Oncol Rep. 2022 Dec;24(12):1741-1750. doi: 10.1007/s11912-022-01338-5. Epub 2022 Oct 18.
2
Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.癌症中的真菌群落与C型凝集素受体:了解你的邻居。
Front Microbiol. 2022 Jul 13;13:946995. doi: 10.3389/fmicb.2022.946995. eCollection 2022.
3
Intestinal Promotes Hepatocarcinogenesis by Up-Regulating NLRP6.
通过患者来源的类器官探索肠道微生物群对胆管癌进展的影响。
J Transl Med. 2025 Jan 9;23(1):34. doi: 10.1186/s12967-024-06012-x.
4
Causal roles of gut microbiota in cholangiocarcinoma etiology suggested by genetic study.基因研究提示肠道微生物群在胆管癌病因学中的因果作用。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1319-1333. doi: 10.4251/wjgo.v16.i4.1319.
5
Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis.通过孟德尔随机化分析阐明肠道微生物群与肝内胆管癌之间的因果关系。
Front Microbiol. 2023 Nov 14;14:1288525. doi: 10.3389/fmicb.2023.1288525. eCollection 2023.
6
Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma-A Scoping Review.胆管癌和胆囊癌诊断、治疗及预后中的肠道微生物群——一项范围综述
Microorganisms. 2023 Sep 21;11(9):2363. doi: 10.3390/microorganisms11092363.
肠道通过上调NLRP6促进肝癌发生。
Front Microbiol. 2022 Mar 8;13:812771. doi: 10.3389/fmicb.2022.812771. eCollection 2022.
4
Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma and .白色念珠菌增强口腔鳞状细胞癌的进展和 。
mBio. 2021 Feb 22;13(1):e0314421. doi: 10.1128/mBio.03144-21. Epub 2022 Jan 4.
5
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.肠道微生物组改变作为原发性肝癌的诊断工具,并与炎症反应标志物相关。
Hepatol Int. 2022 Feb;16(1):99-111. doi: 10.1007/s12072-021-10279-3. Epub 2022 Jan 22.
6
Fungal dysbiosis of the gut microbiota is associated with colorectal cancer in Chinese patients.肠道微生物群的真菌失调与中国患者的结直肠癌有关。
Am J Transl Res. 2021 Oct 15;13(10):11287-11301. eCollection 2021.
7
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.共生细菌和真菌可差异化调节肿瘤对放射疗法的反应。
Cancer Cell. 2021 Sep 13;39(9):1202-1213.e6. doi: 10.1016/j.ccell.2021.07.002. Epub 2021 Jul 29.
8
disorder is associated with gastric carcinogenesis.紊乱与胃癌的发生有关。
Theranostics. 2021 Mar 5;11(10):4945-4956. doi: 10.7150/thno.55209. eCollection 2021.
9
Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22.真菌诱导的巨噬细胞糖酵解通过增强固有淋巴细胞分泌 IL-22 促进结肠癌。
EMBO J. 2021 Jun 1;40(11):e105320. doi: 10.15252/embj.2020105320. Epub 2021 Feb 16.
10
Saccharomyces cerevisiae may serve as a probiotic in colorectal cancer by promoting cancer cell apoptosis.酿酒酵母可通过促进癌细胞凋亡在结直肠癌中作为益生菌发挥作用。
J Dig Dis. 2020 Oct;21(10):571-582. doi: 10.1111/1751-2980.12930. Epub 2020 Sep 29.